Metabolic Dysfunction-Associated Fatty Liver Disease and Mortality: A Population-Based Cohort Study

Kyung-Soo Kim1, Sangmo Hong2, Hong-Yup Ahn3

  • 1Department of Internal Medicine, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea.

Summary

Metabolic dysfunction-associated fatty liver disease (MAFLD) is linked to increased all-cause and cardiovascular mortality. Identifying MAFLD can help pinpoint individuals at higher risk for these adverse outcomes.